Keppra and Eye infection - a phase IV clinical study of FDA data
Summary:
Eye infection is reported as a side effect among people who take Keppra (levetiracetam), especially for people who are female, 50-59 old, also take Dexamethasone, and have Glioblastoma.
The phase IV clinical study analyzes which people have Eye infection when taking Keppra. It is created by eHealthMe based on reports of 70,297 people who have side effects when taking Keppra from the FDA, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Eye infection?
Eye infection is found to be associated with 834 drugs and 768 conditions by eHealthMe. Check the latest studies of Eye infection.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
70,297 people reported to have side effects when taking Keppra.
Among them, 34 people (0.05%) have Eye infection.

Among these 34 people:
What is the gender of people who have Eye infection when taking Keppra? *
- female: 53.12 %
- male: 46.88 %
What is the age of people who have Eye infection when taking Keppra? *
- 0-1: 0.0 %
- 2-9: 15 %
- 10-19: 5 %
- 20-29: 10 %
- 30-39: 0.0 %
- 40-49: 5 %
- 50-59: 50 %
- 60+: 15 %
What are other drugs people take besides Keppra? *
- Dexamethasone: 7 people, 20.59%
- Flonase: 6 people, 17.65%
- Miralax: 6 people, 17.65%
- Tylenol: 6 people, 17.65%
- Vitamin D3: 6 people, 17.65%
- Prilosec: 5 people, 14.71%
- Valcyte: 5 people, 14.71%
- Pantoprazole Sodium: 5 people, 14.71%
- Avastin: 5 people, 14.71%
- Aspirin: 5 people, 14.71%
What are other side effects people have besides Eye infection? *
- Nausea (feeling of having an urge to vomit): 9 people, 26.47%
- Nausea And Vomiting: 9 people, 26.47%
- Headache (pain in head): 9 people, 26.47%
- Fatigue (feeling of tiredness): 9 people, 26.47%
- Confusional State: 6 people, 17.65%
- Fever: 6 people, 17.65%
- Otitis (ear infection): 6 people, 17.65%
- Speech Disorder: 5 people, 14.71%
- Hemiparesis (weakness on one side of the body): 5 people, 14.71%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 14.71%
What are the existing conditions these people have? *
- Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 8 people, 23.53%
- Immunodeficiency Common Variable: 5 people, 14.71%
- Primary Immunodeficiency Syndrome: 3 people, 8.82%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 5.88%
- Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 5.88%
- Multiple Myeloma (cancer of the plasma cells): 2 people, 5.88%
- Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 5.88%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 5.88%
- Hypoglobulinaemia (deficiency of globulin in the bloodstream): 2 people, 5.88%
- Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 2.94%
* Approximation only. Some reports may have incomplete information.
Do you take Keppra and have Eye infection?
- Check whether Eye infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Keppra:
- Keppra (73,504 reports)
Eye infection treatments and more:
- Eye infection (14,222 reports)
How severe was Eye infection and when was it recovered:
Expand to all the drugs that have ingredients of levetiracetam:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Eye infection:
- Eye infection (834 drugs)
Browse all the conditions that are associated with Eye infection:
- Eye infection (768 conditions)
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Keppra) and Keppra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Marijuana and Tylenol - 14 seconds ago
- Could Otezla cause Hypothyroidism? - 14 seconds ago
- Could Tamsulosin cause Hoarseness Or Changing Voice? - 20 seconds ago
- Could Naprosyn cause Ulcerative Colitis? - 23 seconds ago
- Could Evening Primrose Oil cause Itching? - 23 seconds ago
- Could Leucovorin Calcium cause Failure To Thrive? - 24 seconds ago
- Could Ocrevus cause Muscle Aches? - 24 seconds ago
- Could L-Lysine cause Weight Increased? - 28 seconds ago
- Could Lipitor cause Bladder Discomfort? - 29 seconds ago
- Drug interactions of Exforge and Hydramine - 30 seconds ago